| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jun―10 |
Response to Hinpetch Daungsupawong et al. regarding “Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown: Correspondence” |
F. Higuera-de-la-Tijera, F. Lajud-Barquín, A. Tovar-Aguilar |
| 2 |
[GO] |
2025―Jun―09 |
Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown: Correspondence |
H. Daungsupawong, V. Wiwanitkit |
| 3 |
[GO] |
2024―Sep―26 |
Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown are associated with the development of gastrointestinal symptoms |
F. Higuera-de-la-Tijera, A. Servín-Caamaño, F. Lajud-Barquín, A. Tovar-Aguilar |
| 4 |
[GO] |
2024―Jun―13 |
A comparison of endoscopic procedures performed at a tertiary care hospital before and during the SARS-CoV-2 pandemic |
F.E. Zárate-Mondragón, M. Esparza-Aguilar, J.F. Cadena-León, K.R. Ignorosa-Arellano, E. Montijo-Barrios, E.M. Toro-Monjaráz, et al. (+3) R. Cervantes-Bustamante, A.G. Ayala-Germán, J.A. Ramírez-Mayans |
| 5 |
[GO] |
2023―Apr―18 |
Liver injury due to COVID-19 in critically ill adult patients. A retrospective study |
N.V. Alva, O.R. Méndez, J.C. Gasca, I. Salvador, N. Hernández, M. Valdez |
| 6 |
[GO] |
2022―Jul―21 |
Reactive ileal lymphoid hyperplasia related to SARS-CoV-2 infection as a unique clinical feature resembling Crohn’s disease |
R. Qanneta, M. Feliu-Masgoret, G. García-Pardo, F. Marimon-Cortés |
| 7 |
[GO] |
2022―Jul―07 |
Metabolic liver disease: A new preventable pandemic |
M. Hernández-Conde, J.L. Calleja |
| 8 |
[GO] |
2022―Jun―14 |
Impact on the incidence of gastrointestinal perforation during the COVID-19 pandemic in the Costa del Sol healthcare system area |
A.M. Mudarra Vela, F. Rivas Ruiz, J. Atienza Carrasco, F.J. Medina Cano |
| 9 |
[GO] |
2021―Dez―29 |
Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic |
C. Manzano-Aquiahuatl, R. Tobar-Fredes, M.R. Zavala-Solares, D. Salle-Levy, R. Imamura, R. Morales-Fernández, et al. (+7) L. Ojeda-Peña, D. Parra-Reyes, P. Santoro, V. Ton, O.E. Trujillo-Benavides, M.A. Vargas-García, A.M. Furkim |
| 10 |
[GO] |
2021―Dez―03 |
Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one |
R. Maslennikov, V. Ivashkin, A. Ufimtseva, E. Poluektova |
| 11 |
[GO] |
2021―Aug―07 |
Severe bowel complications in SARS-CoV-2 patients receiving protocolized care |
S.C. Estevez-Cerda, J.A. Saldaña-Rodríguez, A.G. Alam-Gidi, A. Riojas-Garza, M. Rodarte-Shade, J. Velazco-de la Garza, et al. (+4) A. Leyva-Alvizo, R. Gonzalez-Ruvalcaba, M.F. Martinez-Resendez, J.I. Ortiz de Elguea-Lizarraga |
| 12 |
[GO] |
2020―Nov―01 |
Recommendations for the reopening and activity resumption of the neurogastroenterology units in the face of the COVID-19 pandemic. Position of the Sociedad Latinoamericana de Neurogastroenterología |
J.M. Remes-Troche, M.A. Valdovinos-Diaz, R. Viebig, C. Defilippi, L.M. Bustos-Fernández, L. Sole, A.C. Hani-Amador |
| 13 |
[GO] |
2020―Okt―10 |
Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus? |
I. García-Juárez, A. Campos-Murguía, V.H. Tovar-Mendez, A. Gabutti, I. Ruiz |
| 14 |
[GO] |
2020―Jul―12 |
Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Position statement within the framework of the SARS-CoV-2 (COVID-19) pandemic |
G. Miranda-Zazueta, J.A. González-Regueiro, I. García-Juárez, C. Moctezuma-Velázquez, F.J. López-Díaz, B. Pérez-González, et al. (+2) L.F. Uscanga-Domínguez, M. Peláez-Luna |
| 15 |
[GO] |
2020―Jul―09 |
Hepatic manifestations and impact of COVID-19 on the cirrhotic patient |
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, J.M. Remes-Troche |
| 16 |
[GO] |
2020―Jun―28 |
Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations |
J.L. de León-Rendón, C. Hurtado-Salazar, J.K. Yamamoto-Furusho |
| 17 |
[GO] |
2020―Mai―31 |
Knowledge of Latin American gastroenterologists and endoscopists regarding SARS-CoV-2 infection |
J. Ruiz-Manriquez, X. León-Lara, A. Campos-Murguía, A.A. Solis-Ortega, B. Pérez-González, L.F. Uscanga, M. Peláez-Luna |
| 18 |
[GO] |
2020―Apr―24 |
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19 |
M. Schmulson, F. Dávalos, J. Berumen |
